So much for the “safe and effective” Covid vax. According to research by the U.S. Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA), published in the Journal of the American Medical Association (JAMA), the CDC and the FDA identified 1,626 authentic cases of myocarditis. They discovered that compared to the background risk in the general population, the risk of myocarditis is 133 times greater in those who took the mRNA injections. The data came from the US government Vaccine Adverse Event Reporting System (VAERS), which has an under-reporting factor of 41-100, which means that the real number of Covid vax injuries is immense. But, we do not hear anything about this from the Australian health authorities, who would probably continue with the “safe and effective” mantra, even if the bodies were stacked 20 high on every street.
https://www.naturalnews.com/2023-06-21-heart-disease-risk-13200-percent-covid-vaccination.html
“The top two public health agencies in the United States conducted a joint study showing that the risk of developing autoimmune heart disease among the “fully vaccinated” for the Wuhan coronavirus (Covid-19) is a shocking 13,200 percent higher than it is among the unvaccinated.
The U.S. Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA) discovered that compared to the background risk in the general population, the risk of myocarditis is 133 times greater in those who took the mRNA injections from either Pfizer-BioNTech or Moderna.
Researchers from several top universities and hospitals across America contributed to the study, which was published in the Journal of the American Medical Association (JAMA).
Using data from the government-run Vaccine Adverse Event Reporting System (VAERS), the CDC and the FDA identified 1,626 cases of myocarditis, which were cross-checked to ensure the results comply with the CDC’s official definition of myocarditis.
Based on this, researchers determined that the most high-risk mRNA jab is the one produced by Pfizer-BioNTech, meaning this one is the most dangerous in terms of potential health effects.
The Pfizer jabs, according to the data provided to VAERS, caused 105.9 cases of myocarditis per million doses after the second injection in the male 16- and 17-year-old age and sex demographic. In the 12-15 age group for males, there were 70.7 cases of myocarditis per million doses following the second shot.
The 18-24 male age group had the highest risk at 52.4 cases per million for Pfizer and 56.3 cases per million for Moderna. The median time to symptom onset was just two days for both jabs.
Since VAERS only captures around 1% of vaccine damage, what is the TRUE risk of autoimmune heart disease following covid injection?
As previous studies have found, the vast majority of covid jab-related heart problems, around 82 percent, occur in males. In the vast majority of cases, around 96 percent, those who became inflicted with myocarditis had to be hospitalized, and in most cases were treated with non-steroidal anti-inflammatory drugs (NSAIDs).
By the time of discharge, 87 percent of those hospitalized saw symptom resolution, at least initially. There is no telling what these people might suffer as the years go by, especially into older age.
Among the most commonly reported symptoms are:
- chest pain, pressure, or discomfort (89 percent)
- shortness of breath (30 percent)
- abnormal ECG results (72 percent)
- abnormal cardiac MRI findings (72 percent)
Recognizing the strong and undeniable link between covid jabs and heart disease, the CDC has commenced an active surveillance program for adolescents and young adults to monitor their progress following these post-injection heart-related incidents.
Since the jabs have only been out since late December 2020, and really only started to get into people’s bodies well into 2021, there is still no long-term data to evaluate concerning the long-term impact of covid jab-related heart disease.
The American Heart Association (AHA) and the American College of Cardiology (ACC) are both advising that people with myocarditis refrain from competitive sports for three to six months, otherwise they could die suddenly on the field.
Only after normal ECG and other test results start to appear should a person afflicted with covid jab-related heart disease even think about resuming strenuous exercise.
By the way, VAERS only captures as little as one percent of all vaccine-related injuries and deaths. So as shocking as these figures and percentages are, one must multiply them by a lot in order to gain a more accurate picture of the injury and death tolls from these injections.
https://jamanetwork.com/journals/jama/fullarticle/2788346
Question What is the risk of myocarditis after mRNA-based COVID-19 vaccination in the US?
Findings In this descriptive study of 1626 cases of myocarditis in a national passive reporting system, the crude reporting rates within 7 days after vaccination exceeded the expected rates across multiple age and sex strata. The rates of myocarditis cases were highest after the second vaccination dose in adolescent males aged 12 to 15 years (70.7 per million doses of the BNT162b2 vaccine), in adolescent males aged 16 to 17 years (105.9 per million doses of the BNT162b2 vaccine), and in young men aged 18 to 24 years (52.4 and 56.3 per million doses of the BNT162b2 vaccine and the mRNA-1273 vaccine, respectively).
Meaning Based on passive surveillance reporting in the US, the risk of myocarditis after receiving mRNA-based COVID-19 vaccines was increased across multiple age and sex strata and was highest after the second vaccination dose in adolescent males and young men.
Abstract
Importance Vaccination against COVID-19 provides clear public health benefits, but vaccination also carries potential risks. The risks and outcomes of myocarditis after COVID-19 vaccination are unclear.
Objective To describe reports of myocarditis and the reporting rates after mRNA-based COVID-19 vaccination in the US.
Design, Setting, and Participants Descriptive study of reports of myocarditis to the Vaccine Adverse Event Reporting System (VAERS) that occurred after mRNA-based COVID-19 vaccine administration between December 2020 and August 2021 in 192 405 448 individuals older than 12 years of age in the US; data were processed by VAERS as of September 30, 2021.
Exposures Vaccination with BNT162b2 (Pfizer-BioNTech) or mRNA-1273 (Moderna).
Main Outcomes and Measures Reports of myocarditis to VAERS were adjudicated and summarized for all age groups. Crude reporting rates were calculated across age and sex strata. Expected rates of myocarditis by age and sex were calculated using 2017-2019 claims data. For persons younger than 30 years of age, medical record reviews and clinician interviews were conducted to describe clinical presentation, diagnostic test results, treatment, and early outcomes.
Results Among 192 405 448 persons receiving a total of 354 100 845 mRNA-based COVID-19 vaccines during the study period, there were 1991 reports of myocarditis to VAERS and 1626 of these reports met the case definition of myocarditis. Of those with myocarditis, the median age was 21 years (IQR, 16-31 years) and the median time to symptom onset was 2 days (IQR, 1-3 days). Males comprised 82% of the myocarditis cases for whom sex was reported. The crude reporting rates for cases of myocarditis within 7 days after COVID-19 vaccination exceeded the expected rates of myocarditis across multiple age and sex strata. The rates of myocarditis were highest after the second vaccination dose in adolescent males aged 12 to 15 years (70.7 per million doses of the BNT162b2 vaccine), in adolescent males aged 16 to 17 years (105.9 per million doses of the BNT162b2 vaccine), and in young men aged 18 to 24 years (52.4 and 56.3 per million doses of the BNT162b2 vaccine and the mRNA-1273 vaccine, respectively). There were 826 cases of myocarditis among those younger than 30 years of age who had detailed clinical information available; of these cases, 792 of 809 (98%) had elevated troponin levels, 569 of 794 (72%) had abnormal electrocardiogram results, and 223 of 312 (72%) had abnormal cardiac magnetic resonance imaging results. Approximately 96% of persons (784/813) were hospitalized and 87% (577/661) of these had resolution of presenting symptoms by hospital discharge. The most common treatment was nonsteroidal anti-inflammatory drugs (589/676; 87%).
Conclusions and Relevance Based on passive surveillance reporting in the US, the risk of myocarditis after receiving mRNA-based COVID-19 vaccines was increased across multiple age and sex strata and was highest after the second vaccination dose in adolescent males and young men. This risk should be considered in the context of the benefits of COVID-19 vaccination.”